U.S. Food and Drug Administration Approves Voxilaprevir - FixHepC

This topic has 4 replies, 3 voices, and was last updated 7 years, 9 months ago by splitdog.

Viewing 4 posts - 1 through 4 (of 4 total)

Author

Posts
19 July 2017 at 12:31 pm #26600
klhilde
- Topics: 30
- Replies: 223
- Total: 253
- Guardian Angel
@klhilde
Ummmm …. so somehow Gilead convinced the FDA to sneak in a 21 day head start on Beacon?
19 July 2017 at 12:48 pm #26601
Dr James
- Topics: 264
- Replies: 1,968
- Total: 2,232
- Guardian Angel
@fixhepc
Wholesale price is rumoured to be $74,760

YMMV
19 July 2017 at 2:29 pm #26603
klhilde
- Topics: 30
- Replies: 223
- Total: 253
- Guardian Angel
@klhilde
Any rumors (or guesses) about pricing from our lovely Bangladeshi competitors?
20 July 2017 at 12:26 am #26608
splitdog
- Topics: 5
- Replies: 374
- Total: 379
- Guardian Angel
@splitdog
“Yee Haw”!!!!!!

splitdog@roadrunner.com

Genotype 3
VL 4,100,000
ALT 101 AST 71
Treatment Naive
Started Sof/Dac Jan 12, 2016
VL= <15 4 weeks in. AST/ALT normal.
VL=UNDETECTED 8 weeks in.
SVR4= Virus back. 3,300,000

Started generic Epclusa Sep. 23, 2017

4 weeks in <15 *Detected.
12 weeks in <15 *Not Detected.
16 weeks in <15 *Not Detected.
Finished 24 weeks treatment 3-17-18
SVR5 <15 Not Detected.
SVR 20 <15 Not Detected.
SVR 44 <15 Not Detected.

Thank you Jesus.
Thank you Dr. James
Author

Posts

Viewing 4 posts - 1 through 4 (of 4 total)

You must be logged in to reply to this topic.